Table 2.
Geographical differences in the uptake of continuous subcutaneous insulin infusion in a whole population, children and adolescents, and adults over 18 with type 1 diabetes in Ireland in 2016
| Geographical area | Uptake of CSII – All (%); (95% CI) | Uptake (%) of CSII in children and adolescents | Uptake (%) of CSII in adults |
|---|---|---|---|
| Carlow Kilkenny | 12.89% (10.30–15.44%) | 39.36% (29.49–49.24%) | 8.64% (6.33–10.95%) |
| Clare | 4.93% (2.82–7.03%) | 24.32% (10.50–38.15%) | 3.01% (1.26–4.77%) |
| Cork Combined | 7.60% (6.53–8.67%) | 31.64% (26.14–37.13%) | 4.43% (3.55–5.32%) |
| Donegal | 9.59% (7.66–11.51%) | 42.86% (34.66–51.05%) | 3.49% (2.17–4.81%) |
| Dublin Combined | 12.59% (11.72–14.36%) | 38.68% (34.80–42.56%) | 9.21% (8.39–10.03%) |
| Galway | 10.69% (8.70–12.68%) | 28.70% (20.43–36.96%) | 7.95% (6.08–9.82%) |
| Kerry | 4.31% (2.75–5.88%) | 20.29% (10.80–29.78%) | 2.43% (1.17–3.69%) |
| Kildare and Wicklow | 15.03% (13.28–16.78%) | 44.00% (37.85–50.15%) | 9.63% (8.03–11.24%) |
| Laois and Offaly | 10.72% (8.29–13.15%) | 30.53% (21.27–39.79%) | 7.03% (4.85–9.22%) |
| Limerick and Tipperary | 7.75% (6.38–9.12%) | 29.25% (23.12–35.37%) | 4.03% (2.93–5.14%) |
| Longford Westmeath | 9.67% (7.12–12.22%) | 27.50% (17.72–37.28%) | 6.56% (4.21–8.91%) |
| Louth | 11.77% (9.33–14.21%) | 38.78% (29.13–48.42%) | 7.09% (4.97–9.21%) |
| Mayo | 6.86% (4.70–9.02%) | 12.64% (5.66–19.63%) | 5.50% (3.36–7.65%) |
| Meath | 15.76% (13.21–18.30%) | 53.66% (44.85–62.47%) | 8.79% (6.63–10.95%) |
| Roscommon | 4.00% (1.44–6.56%) | 18.52% (3.87–33.17%) | 2.03% (0.06–4.00%) |
| Sligo, Leitrim, Cavan, Monaghan | 8.55% (6.80–10.30%) | 30.58% (22.37–39.79%) | 5.32% (3.81–6.83%) |
| Waterford City and County | 8.15% (5.73–10.57%) | 20.45% (12.03–28.88%) | 5.33% (3.11–7.55%) |
| Wexford | 9.55% (7.42–11.68%) | 36.00% (25.14–46.86%) | 6.31% (4.42–8.20%) |
| ALL IRELAND | 10.51% (10.09–10.94%) | 34.70% (32.86–36.53%) | 6.81% (6.44–7.19%) |